06.12.2012 Views

LEGIONELLA - World Health Organization

LEGIONELLA - World Health Organization

LEGIONELLA - World Health Organization

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Parenteral therapy is usually given at least until there is a clinical response, although outpatients<br />

with mild disease do well with oral therapy. Most patients recover from fever within 3–5 days.<br />

Total duration of treatment is normally 10–14 days (5–10 days for azithromycin), but a<br />

21-day course has been recommended for immunosuppressed patients, as well as for those<br />

with severe disease (e.g. extensive evidence of disease on chest radiographs). However, chest<br />

X-rays are not effective for monitoring the success of the therapy (see Section 1.1.1).<br />

Adverse effects<br />

The principal adverse effects of a macrolide treatment include gastrointestinal symptoms,<br />

such as diarrhoea and vomiting, and effects on the ears (when given in high doses). Relatively<br />

frequently, the respiratory fluoroquinolones cause adverse effects such as gastrointestinal<br />

symptoms and central nervous system disturbances. Alteration to the electrocardiogram<br />

(ECG or EKG) (i.e. prolongation of the QT interval — the duration of the contraction of the<br />

heart’s main chambers) precludes the use of these quinolones in patients with severe electrolyte<br />

imbalances, irregular heartbeats or severe congestive heart failure. Erythromycin has also been<br />

reported to cause ventricular fibrillation (disorganized twitching of the heart muscle) and QT<br />

prolongation, and should be used with caution in patients with heart disease, especially when the<br />

drug is rapidly administered into the bloodstream via a central venous catheter.<br />

1.4 Types of organism causing disease<br />

1.4.1 Taxonomy<br />

Since Legionnaires’ disease was recognized, characterization of the strains isolated from patients<br />

has led to the creation of a new bacterial genus, Legionella, belonging to the family Legionellaceae<br />

(Brenner, Steigerwalt & McDade, 1979). Some investigators (Garrity, Brown & Vickers, 1980;<br />

Brown, Garrity & Vickers, 1981) have proposed placing the legionellae in three separate<br />

genera — Legionella, Fluoribacter and Tatlockia — on the basis of low DNA (deoxyribonucleic<br />

acid) hybridization values between some Legionella species (Fox & Brown, 1993). However,<br />

other studies have shown that the family Legionellaceae forms a single subgroup, sharing a common<br />

ancestor within the gamma-s subdivision of the Proteobacteria. Data using 16S ribosomal<br />

RNA (ribonucleic acid) analysis support a single family, showing that all legionellae studied<br />

are more than 95% related (Fry et al., 1991).<br />

Within the genus Legionella, the DNA relatedness between strains of a given species is unusually<br />

high (>90%), whereas DNA relatedness between one species and another is less than 70%<br />

(Brenner, 1986). Many definitions for bacterial genera and species have been suggested; however,<br />

it is likely that the integrated use of phylogenetic and phenotypic characters is necessary for<br />

the delineation of bacterial taxa at all levels (Murray et al, 1990). The nearest genetic relative<br />

to Legionellaceae is Coxiella burnetti (Marti, Garcia & Bustillo, 1990), the cause of Q fever.<br />

The Legionellacae and C. burnetti have similar intracellular lifestyles, and may have common<br />

genes associated with the infection processes in their hosts.<br />

<strong>LEGIONELLA</strong> AND THE PREVENTION OF LEGIONELLOSIS

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!